182 related articles for article (PubMed ID: 29070518)
61. Effect and Mechanism of Tanshinone I on the Radiosensitivity of Lung Cancer Cells.
Yan Y; Su W; Zeng S; Qian L; Chen X; Wei J; Chen N; Gong Z; Xu Z
Mol Pharm; 2018 Nov; 15(11):4843-4853. PubMed ID: 30216081
[TBL] [Abstract][Full Text] [Related]
62. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Raju U; Nakata E; Mason KA; Ang KK; Milas L
Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
[TBL] [Abstract][Full Text] [Related]
63. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.
Kang J; Kim W; Kwon T; Youn H; Kim JS; Youn B
Oncotarget; 2016 Apr; 7(17):23961-74. PubMed ID: 27004408
[TBL] [Abstract][Full Text] [Related]
64. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
65. Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412.
Zaugg K; Rocha S; Resch H; Hegyi I; Oehler C; Glanzmann C; Fabbro D; Bodis S; Pruschy M
Cancer Res; 2001 Jan; 61(2):732-8. PubMed ID: 11212276
[TBL] [Abstract][Full Text] [Related]
66. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
[TBL] [Abstract][Full Text] [Related]
67. Novel focal adhesion kinase 1 inhibitor sensitizes lung cancer cells to radiation in a p53-independent manner.
Jung SY; Kho S; Song KH; Ahn J; Park IC; Nam KY; Hwang SG; Nam SY; Cho SJ; Song JY
Int J Oncol; 2017 Nov; 51(5):1583-1589. PubMed ID: 29048635
[TBL] [Abstract][Full Text] [Related]
68. Artesunate enhances radiosensitivity of esophageal cancer cells by inhibiting the repair of DNA damage.
Fei Z; Gu W; Xie R; Su H; Jiang Y
J Pharmacol Sci; 2018 Oct; 138(2):131-137. PubMed ID: 30337244
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of connectivity map-discovered celastrol as a radiosensitizing agent in a murine lung carcinoma model: Feasibility study of diffusion-weighted magnetic resonance imaging.
Jun HY; Kim TH; Choi JW; Lee YH; Lee KK; Yoon KH
PLoS One; 2017; 12(5):e0178204. PubMed ID: 28542649
[TBL] [Abstract][Full Text] [Related]
70. Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models.
Thotala D; Craft JM; Ferraro DJ; Kotipatruni RP; Bhave SR; Jaboin JJ; Hallahan DE
PLoS One; 2013; 8(7):e69688. PubMed ID: 23894523
[TBL] [Abstract][Full Text] [Related]
71. Non‑thermal plasma inhibits tumor growth and proliferation and enhances the sensitivity to radiation in vitro and in vivo.
Lin L; Wang L; Liu Y; Xu C; Tu Y; Zhou J
Oncol Rep; 2018 Dec; 40(6):3405-3415. PubMed ID: 30272342
[TBL] [Abstract][Full Text] [Related]
72. The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
Xu MD; Liu SL; Zheng BB; Wu J; Wu MY; Zhang Y; Gong FR; Tao M; Zhang J; Li W
Pancreatology; 2018 Oct; 18(7):822-832. PubMed ID: 30201439
[TBL] [Abstract][Full Text] [Related]
73. The poly (ADP-ribose) polymerase inhibitor rucaparib suppresses proliferation and serves as an effective radiosensitizer in cervical cancer.
Tang M; Liu Q; Zhou L; Chen L; Yang X; Yu J; Wang Y; Qiu H
Invest New Drugs; 2019 Feb; 37(1):65-75. PubMed ID: 29872938
[TBL] [Abstract][Full Text] [Related]
74. Identification of FES as a Novel Radiosensitizing Target in Human Cancers.
Kim BH; Kim YJ; Kim MH; Na YR; Jung D; Seok SH; Kim J; Kim HJ
Clin Cancer Res; 2020 Jan; 26(1):265-273. PubMed ID: 31573955
[TBL] [Abstract][Full Text] [Related]
75. Investigation of radiation-induced transcriptome profile of radioresistant non-small cell lung cancer A549 cells using RNA-seq.
Yang HJ; Kim N; Seong KM; Youn H; Youn B
PLoS One; 2013; 8(3):e59319. PubMed ID: 23533613
[TBL] [Abstract][Full Text] [Related]
76. A phthalimidoalkanamide derived novel DNMT inhibitor enhanced radiosensitivity of A549 cells by inhibition of homologous recombination of DNA damage.
Kang HC; Chie EK; Kim HJ; Kim JH; Kim IH; Kim K; Shin BS; Ma E
Invest New Drugs; 2019 Dec; 37(6):1158-1165. PubMed ID: 30793218
[TBL] [Abstract][Full Text] [Related]
77. Enhancement of recombinant myricetin on the radiosensitivity of lung cancer A549 and H1299 cells.
Zhang S; Wang L; Liu H; Zhao G; Ming L
Diagn Pathol; 2014 Mar; 9():68. PubMed ID: 24650056
[TBL] [Abstract][Full Text] [Related]
78. Downregulation of peroxiredoxin-1 by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenografts.
Li G; Xie B; Li X; Chen Y; Xu Y; Xu-Welliver M; Zou L
Oncol Rep; 2015 Mar; 33(3):1427-33. PubMed ID: 25607351
[TBL] [Abstract][Full Text] [Related]
79. FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells.
Li JL; Wang JP; Chang H; Deng SM; Du JH; Wang XX; Hu HJ; Li DY; Xu XB; Guo WQ; Song YH; Guo Z; Sun MX; Wu YW; Liu SB
Cancer Med; 2019 Dec; 8(18):7774-7780. PubMed ID: 31670906
[TBL] [Abstract][Full Text] [Related]
80. Downregulation of BIS sensitizes A549 cells for digoxin-mediated inhibition of invasion and migration by the STAT3-dependent pathway.
Yun HH; Kim S; Kuh HJ; Lee JH
Biochem Biophys Res Commun; 2020 Apr; 524(3):643-648. PubMed ID: 32029272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
